On the heels of Johnson & Johnson's loss in a California Superior Court case regarding their DePuy ASR Hip implant, the second DePuy ASR Hip lawsuit started on March 11…
Read More
The first transvaginal mesh lawsuit in the Ethicon multidistrict litigation (MDL) in a West Virginia federal court has reportedly discontinued proceedings following a ruling for dismissal handed down by the…
Read More
As a national law firm that practices defective drug and personal injury litigation, Carey Danis & Lowe has worked on numerous cases where a pharmaceutical company misrepresented a product, and…
Read More
Should older men use testosterone applied to the skin, such as testosterone gel, or should they inject testosterone into their muscles? A new study published in April 2015 in the…
Read More
A woman who participated in a Washington University School of Medicine study claims to have sustained permanent injuries from the intrauterine contraceptive device (IUD), Mirena. The research study supplied participants…
Read More
The German pharmaceutical company responsible for the anticoagulant drug, Pradaxa, offered a $650 million settlement package to wrap up thousands of Pradaxa lawsuits in the U.S. In the statement announcing…
Read More
The Ontario Superior Court of Justice has approved a Yaz and Yasmin class action lawsuit. The lawsuit includes all women residing in Ontario and Quebec who used Yaz and/or Yasmin…
Read More
Over 100 Obtape vaginal mesh lawsuits have been settled in the Obtape multidistrict litigation (MDL) in Georgia. The mesh lawsuit settlement covers 111 cases involving the Mentor Obtape Transobturator Sling.…
Read More
The Huffington Post recently published an article in which the author describes her experience using the NuvaRing contraceptive device. Writing for the Huffington Post, Nancy Polanco describes using the NuvaRing…
Read More
The NuvaRing Master Settlement Agreement drawn up in February 2014 for the NuvaRing multidistrict litigation (MDL) being heard in Missouri has been accepted by both parties, and is moving forward…
Read More